The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Photo of Shai Mulinari. Private photo.

Shai Mulinari

Associate Professor | Senior Lecturer

Photo of Shai Mulinari. Private photo.

Exposing drug industry funding of UK patient organisations

Author

  • Piotr Ozieranski
  • Emily Richard
  • Shai Mulinari

Summary, in English

From 2012 to 2016 the drug industry donated over £57m (€65m; $73m) to UK patient organisations, with the annual sum more than doubling over the period. The funding benefited a small number of organisations and activities related to research and public involvement. The industry gave priority to commercially high profile conditions. Industry payment disclosures had limited transparency

Department/s

  • Sociology

Publishing year

2019-05-23

Language

English

Publication/Series

BMJ: British Medical Journal

Volume

365

Document type

Journal article

Publisher

BMJ Publishing Group

Topic

  • Health Care Service and Management, Health Policy and Services and Health Economy
  • Sociology (excluding Social Work, Social Psychology and Social Anthropology)

Status

Published

Project

  • What can be learnt from the new pharmaceutical industry payment disclosures? A network and policy analysis of ties between companies and health professionals and organisations

ISBN/ISSN/Other

  • ISSN: 1756-1833